TMC Life Sciences Bhd (0101) - Cash Flow Conversion Efficiency
Based on the latest financial reports, TMC Life Sciences Bhd (0101) has a cash flow conversion efficiency ratio of 0.026x as of February 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (RM22.16 Million ≈ $5.56 Million USD) by net assets (RM862.53 Million ≈ $216.55 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See 0101 equity to assets ratio to measure how much of total assets are equity-financed.
TMC Life Sciences Bhd - Cash Flow Conversion Efficiency Trend (2006–2025)
This chart illustrates how TMC Life Sciences Bhd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check TMC Life Sciences Bhd cash flow quality index to evaluate the quality of earnings relative to operating cash generation.
TMC Life Sciences Bhd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of TMC Life Sciences Bhd ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Grupo Minsa S.A.B. de C.V
MX:MINSAB
|
0.009x |
|
Samara Asset Group
F:SRAG
|
N/A |
|
Wuhan Golden Laser Co Ltd
SHE:300220
|
0.121x |
|
HomeChoice Investments Ltd
JSE:HIL
|
-0.138x |
|
Vakif Gayrimenkul Yatirim Ortakligi AS
IS:VKGYO
|
0.038x |
|
Datawalk SA
WAR:DAT
|
-1.044x |
|
Circio Holding ASA
OL:CRNA
|
2.054x |
|
Alpha Teknova Inc
NASDAQ:TKNO
|
-0.052x |
Annual Cash Flow Conversion Efficiency for TMC Life Sciences Bhd (2006–2025)
The table below shows the annual cash flow conversion efficiency of TMC Life Sciences Bhd from 2006 to 2025. For the full company profile with market capitalisation and key ratios, see market cap of TMC Life Sciences Bhd.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-08-31 | RM853.04 Million ≈ $214.17 Million |
RM22.51 Million ≈ $5.65 Million |
0.026x | -70.80% |
| 2024-08-31 | RM888.03 Million ≈ $222.96 Million |
RM80.23 Million ≈ $20.14 Million |
0.090x | +42.70% |
| 2023-08-31 | RM861.96 Million ≈ $216.41 Million |
RM54.57 Million ≈ $13.70 Million |
0.063x | +46.01% |
| 2022-08-31 | RM827.39 Million ≈ $207.73 Million |
RM35.88 Million ≈ $9.01 Million |
0.043x | +52.51% |
| 2021-08-31 | RM789.62 Million ≈ $198.25 Million |
RM22.45 Million ≈ $5.64 Million |
0.028x | +21.41% |
| 2020-08-31 | RM772.12 Million ≈ $193.85 Million |
RM18.08 Million ≈ $4.54 Million |
0.023x | -40.88% |
| 2019-08-31 | RM762.24 Million ≈ $191.37 Million |
RM30.19 Million ≈ $7.58 Million |
0.040x | +13.48% |
| 2018-08-31 | RM740.24 Million ≈ $185.85 Million |
RM25.84 Million ≈ $6.49 Million |
0.035x | +151.91% |
| 2017-08-31 | RM714.42 Million ≈ $179.37 Million |
RM9.90 Million ≈ $2.49 Million |
0.014x | -75.44% |
| 2016-08-31 | RM634.26 Million ≈ $159.24 Million |
RM35.79 Million ≈ $8.99 Million |
0.056x | +58.75% |
| 2015-08-31 | RM301.71 Million ≈ $75.75 Million |
RM10.72 Million ≈ $2.69 Million |
0.036x | -58.89% |
| 2014-08-31 | RM135.39 Million ≈ $33.99 Million |
RM11.71 Million ≈ $2.94 Million |
0.086x | +40.65% |
| 2013-08-31 | RM131.31 Million ≈ $32.97 Million |
RM8.07 Million ≈ $2.03 Million |
0.061x | +297.50% |
| 2012-08-31 | RM120.19 Million ≈ $30.18 Million |
RM-3.74 Million ≈ $-939.24K |
-0.031x | -134.12% |
| 2011-08-31 | RM66.04 Million ≈ $16.58 Million |
RM6.02 Million ≈ $1.51 Million |
0.091x | -25.70% |
| 2009-08-31 | RM103.54 Million ≈ $25.99 Million |
RM12.71 Million ≈ $3.19 Million |
0.123x | +178.84% |
| 2008-08-31 | RM114.02 Million ≈ $28.63 Million |
RM-17.75 Million ≈ $-4.46 Million |
-0.156x | -213.70% |
| 2007-08-31 | RM75.33 Million ≈ $18.91 Million |
RM10.32 Million ≈ $2.59 Million |
0.137x | -47.73% |
| 2006-08-31 | RM48.97 Million ≈ $12.29 Million |
RM12.83 Million ≈ $3.22 Million |
0.262x | -- |
About TMC Life Sciences Bhd
TMC Life Sciences Berhad, an investment holding company, provides healthcare services in Malaysia. The company operates Thomson Hospital Kota Damansara hospital located in prime alcove of Kota Damansara. It is involved in providing multi-disciplinary tertiary care, traditional and complementary, obstetrics and gynaecology, fertility services; operating fertility centres and women clinics; propert… Read more